Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

BACKGROUND: Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouairi, Fouad, Mullan, Clancy W., Sen, Sounok, Mori, Makoto, Fuery, Michael, Elder, Robert W., Lesse, Joshua, Norton, Kelsey, Clark, Katherine A., Miller, P. Elliott, Mulligan, David, Formica, Richard, Rogers, Joseph G., Jacoby, Daniel, Maulion, Christopher, Anwer, Muhammad, Geirsson, Arnar, Desai, Nihar R., Ahmad, Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924739/
https://www.ncbi.nlm.nih.gov/pubmed/33651802
http://dx.doi.org/10.1371/journal.pone.0247789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924739/
https://www.ncbi.nlm.nih.gov/pubmed/33651802
http://dx.doi.org/10.1371/journal.pone.0247789

Ejemplares similares